I would use caution in saying Brilacidin works great based on some of the recent companionate use posts we’ve seen lately. I mean, it sounds like it did work in eliminating the virus, but based on prior studies and trials, we almost knew for sure that would be the case. But once a patient is intubated the virus has already won, cytokine storm has set in and pulmonary fibrosis is developing or about to. I don’t think that being “Covid free” is very helpful if a patient is already intubated. I lost a family member to covid and he was covid negative maybe within a week or two (I can’t remember exactly) of being intubated, but it was too late.

If Brilacidin can improve outcomes in patients that are already intubated, it would be a minor miracle and likely due to its strong anti inflammatory properties. If that’s the case it truly would be the cure for covid.

But even if Brilacidin can’t do that, fortunately for us, the trial was run in moderate to severe Covid patients, and that is a totally different patient population than compassionate use patients. Mechanical ventilation was an exclusion criterion in the trial whic means none of the participants were intubated before they got Brilacidin. Hopefully early dosing will allow Brilacidin to significantly improve outcomes, which I think it will.

But I agree, we should continue to hope and pray Brilacidin, or anything else, can help compassionate use patients, for their and their family’s sake, to give them some sort of hope and comfort, because they are hurting